King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

1
Player Avatar RxIntern (< 20) Submitted: 9/6/2008 1:31:14 AM : Outperform Start Price: $11.99 KG Score: +12.34

New Pain Meds = high profits!

Featured Broker Partners


Advertisement